Cargando…
Surgical Treatment of Distal Cholangiocarcinoma
Distal cholangiocarcinoma (dCCA) is a rare malignancy arising from the epithelial cells of the distal biliary tract and has a poor prognosis. dCCA is often clinically silent and patients commonly present with locally advanced and/or distant disease. For patients identified with early stage, resectab...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498206/ https://www.ncbi.nlm.nih.gov/pubmed/36135093 http://dx.doi.org/10.3390/curroncol29090524 |
_version_ | 1784794699824889856 |
---|---|
author | Gorji, Leva Beal, Eliza W. |
author_facet | Gorji, Leva Beal, Eliza W. |
author_sort | Gorji, Leva |
collection | PubMed |
description | Distal cholangiocarcinoma (dCCA) is a rare malignancy arising from the epithelial cells of the distal biliary tract and has a poor prognosis. dCCA is often clinically silent and patients commonly present with locally advanced and/or distant disease. For patients identified with early stage, resectable disease, surgical resection with negative margins remains the only curative treatment strategy available. However, despite appropriate treatment and diligent surveillance, risk of recurrence remains high with nearly 50% of patients experiencing recurrence at 5 years subsequent to surgical resection; therefore, it is prudent to continue to optimize neoadjuvant and adjuvant therapies in order to reduce the risk of recurrence and improve overall survival. In this review, we discuss the clinical presentation, workup and surgical treatment of dCCA. |
format | Online Article Text |
id | pubmed-9498206 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94982062022-09-23 Surgical Treatment of Distal Cholangiocarcinoma Gorji, Leva Beal, Eliza W. Curr Oncol Review Distal cholangiocarcinoma (dCCA) is a rare malignancy arising from the epithelial cells of the distal biliary tract and has a poor prognosis. dCCA is often clinically silent and patients commonly present with locally advanced and/or distant disease. For patients identified with early stage, resectable disease, surgical resection with negative margins remains the only curative treatment strategy available. However, despite appropriate treatment and diligent surveillance, risk of recurrence remains high with nearly 50% of patients experiencing recurrence at 5 years subsequent to surgical resection; therefore, it is prudent to continue to optimize neoadjuvant and adjuvant therapies in order to reduce the risk of recurrence and improve overall survival. In this review, we discuss the clinical presentation, workup and surgical treatment of dCCA. MDPI 2022-09-17 /pmc/articles/PMC9498206/ /pubmed/36135093 http://dx.doi.org/10.3390/curroncol29090524 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Gorji, Leva Beal, Eliza W. Surgical Treatment of Distal Cholangiocarcinoma |
title | Surgical Treatment of Distal Cholangiocarcinoma |
title_full | Surgical Treatment of Distal Cholangiocarcinoma |
title_fullStr | Surgical Treatment of Distal Cholangiocarcinoma |
title_full_unstemmed | Surgical Treatment of Distal Cholangiocarcinoma |
title_short | Surgical Treatment of Distal Cholangiocarcinoma |
title_sort | surgical treatment of distal cholangiocarcinoma |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498206/ https://www.ncbi.nlm.nih.gov/pubmed/36135093 http://dx.doi.org/10.3390/curroncol29090524 |
work_keys_str_mv | AT gorjileva surgicaltreatmentofdistalcholangiocarcinoma AT bealelizaw surgicaltreatmentofdistalcholangiocarcinoma |